Literature DB >> 21396966

Long-term effects of cytokine treatment on cognitive behavioral recovery and neuronal regeneration in soman-poisoned mice.

Jean-Marc Collombet1, Daniel Béracochéa, Pierrette Liscia, Christophe Piérard, Guy Lallement, Pierre Filliat.   

Abstract

Increasing numbers of reports have substantiated to date, a beneficial influence of cytokine treatment on neurogenesis processes in damaged rodent brains. Most of these investigations further revealed that cytokine treatment induces either partial or full recovery of cognitive behavior impaired by cerebral lesions. Hence, we investigated the effects of a cytokine treatment on neuronal regeneration and cognitive behavior in mice subjected to nerve agent exposure. Subcutaneous injection of a mixture of 40 μg/kg fibroblast growth factor-2 (FGF-2) and epidermal growth factor (EGF) was administered daily over 8 days to soman-poisoned mice (1.2 LD50 soman). Memory performances (T-maze and Morris water maze) and emotional behavior (elevated plus maze; auditory and contextual response in a fear conditioning task) were assessed on post-soman days 30 and 90. Brains were collected on post-soman days 9, 30 and 90 so as to perform NeuN-immunohistochemistry in the hippocampus and amygdala (neuronal regeneration quantification). Following soman-induced brain lesions, a spontaneous neuronal regeneration occurred in both the hippocampus and amygdala. Cytokine treatment enhanced neuronal regeneration in the hippocampus however not in the amygdala. Soman poisoning fostered altogether memory impairments as well as anxiety or fear-like behavioral disturbances in mice. A spontaneous recovery of standard emotional behavior occurred overtime. Such a recovery displayed significantly enhanced speed under cytokine treatment. Unfortunately, no memory performance recovery was evidenced in soman-intoxicated mice whether treated or not with cytokines.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21396966     DOI: 10.1016/j.bbr.2011.03.006

Source DB:  PubMed          Journal:  Behav Brain Res        ISSN: 0166-4328            Impact factor:   3.332


  10 in total

Review 1.  A review of experimental evidence linking neurotoxic organophosphorus compounds and inflammation.

Authors:  Christopher N Banks; Pamela J Lein
Journal:  Neurotoxicology       Date:  2012-02-10       Impact factor: 4.294

2.  Serum epidermal growth factor predicts cognitive functions in early, drug-naive Parkinson's disease patients.

Authors:  Maria Teresa Pellecchia; Gabriella Santangelo; Marina Picillo; Rosario Pivonello; Katia Longo; Claudia Pivonello; Carmine Vitale; Marianna Amboni; Anna De Rosa; Marcello Moccia; Roberto Erro; Giuseppe De Michele; Lucio Santoro; Annamaria Colao; Paolo Barone
Journal:  J Neurol       Date:  2012-08-22       Impact factor: 4.849

3.  LY293558 prevents soman-induced pathophysiological alterations in the basolateral amygdala and the development of anxiety.

Authors:  Eric M Prager; Taiza H Figueiredo; Robert P Long; Vassiliki Aroniadou-Anderjaska; James P Apland; Maria F M Braga
Journal:  Neuropharmacology       Date:  2014-09-06       Impact factor: 5.250

Review 4.  Long-term neuropathological and behavioral impairments after exposure to nerve agents.

Authors:  Vassiliki Aroniadou-Anderjaska; Taiza H Figueiredo; James P Apland; Eric M Prager; Volodymyr I Pidoplichko; Steven L Miller; Maria F M Braga
Journal:  Ann N Y Acad Sci       Date:  2016-03-22       Impact factor: 5.691

5.  Recombinant human fibroblast growth factor-2 promotes nerve regeneration and functional recovery after mental nerve crush injury.

Authors:  Sung Ho Lee; Wei-Peng Jin; Na Ri Seo; Kang-Mi Pang; Bongju Kim; Soung-Min Kim; Jong-Ho Lee
Journal:  Neural Regen Res       Date:  2017-04       Impact factor: 5.135

6.  Persistent neuroinflammation and cognitive impairment in a rat model of acute diisopropylfluorophosphate intoxication.

Authors:  Brenna M Flannery; Donald A Bruun; Douglas J Rowland; Christopher N Banks; Adam T Austin; David L Kukis; Yonggang Li; Byron D Ford; Daniel J Tancredi; Jill L Silverman; Simon R Cherry; Pamela J Lein
Journal:  J Neuroinflammation       Date:  2016-10-12       Impact factor: 8.322

7.  Advances in toxicology and medical treatment of chemical warfare nerve agents.

Authors:  Mohammd Moshiri; Emadodin Darchini-Maragheh; Mahdi Balali-Mood
Journal:  Daru       Date:  2012-11-28       Impact factor: 3.117

8.  Recent advances in the treatment of organophosphorous poisonings.

Authors:  Mahdi Balali-Mood; Hamidreza Saber
Journal:  Iran J Med Sci       Date:  2012-06

9.  Houttuynia cordata Improves Cognitive Deficits in Cholinergic Dysfunction Alzheimer's Disease-Like Models.

Authors:  Eugene Huh; Hyo Geun Kim; Hanbyeol Park; Min Seo Kang; Bongyong Lee; Myung Sook Oh
Journal:  Biomol Ther (Seoul)       Date:  2014-05       Impact factor: 4.634

10.  Decreased Serum EGF in First-episode and Chronic Schizophrenia Patients: Negative Correlation with Psychopathology.

Authors:  Xiaobin Zhang; Wenhuan Xiao; KuanYu Chen; Yaqin Zhao; Fei Ye; Xiaowei Tang; Xiangdong Du
Journal:  Sci Rep       Date:  2020-04-16       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.